Skip to Content
Merck
  • Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.

Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.

The New England journal of medicine (1976-12-23)
A Cohen, D Doyle, D W Martin, A J Ammann
PMID825775
ABSTRACT

To delineate the normal function of purine nucleoside phosphorylase and to understand the pathogenesis of the immune dysfunction associated with deficiency of this enzyme, we studied purine metabolism in a patient deficient in purine nucleoside phosphorylase, her erythrocytes and cultured fibroblasts. She exhibited severe hypouricemia and hypouricosuria but excreted excessive amounts of purines in her urine, the major components of which were inosine and guanosine. Her urine also contained deoxyinosine, deoxyguanosine and uric acid 9-N riboside. The patient's erythrocytes but not her cultured fibroblasts contained increased concentrations of phosphoribosylpyrophosphate and inosine. The metabolic abnormalities resembled those in the erythrocytes of patients with the Lesch-Nyhan syndrome. Purine nucleoside phosphorylase is a necessary component of the major, if not the sole, pathway for the conversion of purine nucleosides and nucleotides to uric acid. The increased intracellular concentrations of inosine may, by inhibiting adenosine deaminase, be related to the immunologic dysfunction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2′-Deoxyinosine, ≥98%